The flinders sensitive line rat model of depression-25 years and still producing

Pharmacological Reviews

Volumn 65, Issue 1, 2013, Pages 143-155

  Overstreet, David H ^a   Wegener, Gregers ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY   (Denmark)

^c NORTH WEST UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DYFLOS; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; NEUROPEPTIDE Y; POTASSIUM CHANNEL; SEROTONIN;

ANHEDONIA; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; CONSTRUCT VALIDITY; DEPRESSION; EXAGGERATED SWIM TEST; EXPERIMENTAL BEHAVIORAL TEST; EXPERIMENTAL DEPRESSION TEST; FACE VALIDITY; FAWN HOODED RAT; FLINDERS SENSITIVE LINE RAT; FORCED SWIM TEST; HUMAN; MATERNAL BEHAVIOR; MOTIVATION; NONHUMAN; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; RAT; RAT STRAIN; REVIEW; SOCIAL INTERACTION TEST; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DEPRESSION; DISEASE MODELS, ANIMAL; HUMANS; MATERNAL BEHAVIOR; POTASSIUM CHANNELS; RATS;

MLCS; MLOWN;

EID: 84877837445     PISSN: 00316997     EISSN: 15210081     Source Type: Journal    
DOI: 10.1124/pr.111.005397     Document Type: Review

References (155)

1. Abildgaard A., Solskov L, Volke V, Harvey BH, Lund S, and Wegener G (2011) A highfat diet exacerbates depressive-like behavior in the Flinders Sensitive Line (FSL) rat, a genetic model of depression. Psychoneuroendocrinology 36:623-633.
2. Angelucci F., Aloe L, Jiménez-Vasquez P, and Mathé AA (2003) Electroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression. Neuropeptides 37:51-56.
3. Arora R. C, Tong C, Jackman HL, Stoff D, and Meltzer HY (1983) Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-hooded and Sprague Dawley rats. Life Sci 33:437-442.
4. Aulakh C. S, Tolliver T, Wozniak KM, Hill JL, and Murphy DL (1994) Functional and biochemical evidence for altered serotonergic function in the fawn-hooded rat strain. Pharmacol Biochem Behav 49:615-620.
5. Bale T. L (2006) Stress sensitivity and the development of affective disorders. Horm Behav 50:529-533.
6. Benca R. M, Overstreet DE, Gilliland MA, Russell D, Bergmann BM, and Obermeyer WH (1996) Increased basal REM sleep but no difference in dark induction or light suppression of REM sleep in flinders rats with cholinergic supersensitivity. Neuropsychopharmacology 15:45-51.
7. Bendotti C. and Samanin R (1987) The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats. Life Sci 41:635-642.
8. Braw Y., Malkesman O, Dagan M, Bercovich A, Lavi-Avnon Y, Schroeder M, Overstreet DH, and Weller A (2006) Anxiety-like behaviors in pre-pubertal rats of the Flinders Sensitive Line (FSL) and Wistar-Kyoto (WKY) animal models of depression. Behav Brain Res 167:261-269.
9. Caberlotto L., Jimenez PA, Overstreet DH, Hurd YL, Mathé AA, and Fuxe K (1999) Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression. Neurosci Lett 265:191-194.
10. Carboni L., Becchi S, Piubelli C, Mallei A, Giambelli R, Razzoli M, Mathé AA, Popoli M, and Domenici E (2010) Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 34:1037-1048.
11. Chen F., Madsen TM, Wegener G, and Nyengaard JR (2010) Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression. Hippocampus 20:1376-1384.
12. Chen F., Wegener G, Madsen TM, and Nyengaard JR (2012) Mitochondria plasticity of the hippocampus in a genetic rat depression model after antidepressant treatment. Synapse DOI: 10.1002/syn.21622 [Epub ahead of print]
13. Costa A. C, Stasko MR, Stoffel M, and Scott-McKean JJ (2005) G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responses. J Neurosci 25:7801-7804.
14. Crocker A. D and Overstreet DH (1991) Dopamine sensitivity in rats selectively bred for increases in cholinergic function. Pharmacol Biochem Behav 38:105-108.
15. Dalla C., Pitychoutis PM, Kokras N, and Papadopoulou-Daifoti Z (2011) Sex differences in response to stress and expression of depressive-like behaviours in the rat. Curr Top Behav Neurosci 8:97-118.
16. Daws L. C and Overstreet DH (1999) Ontogeny of muscarinic cholinergic supersensitivity in the Flinders Sensitive Line rat. Pharmacol Biochem Behav 62:367-380.
17. De Kloet E. R, Vreugdenhil E, Oitzl MS, and Joëls M (1998) Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301.
18. Deuschle M., Schweiger U, Weber B, Gotthardt U, Körner A, Schmider J, Standhardt H, Lammers CH, and Heuser I (1997) Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J Clin Endocrinol Metab 82:234-238.
19. Dilsaver S. C, Peck JA, and Overstreet DH. (1991) The Flinders Sensitive Lin rat exhibits enhanced thermic responsiveness to nicotine relative to the Sprague-Dawley rat. Pharmacol Biochem Behav 41:23-27.
20. Drevets W. C and Furey ML (2010) Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatry 67:432-438.
21. Dugovic C., Solberg LC, Redei E, Van Reeth O, and Turek FW (2000) Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. Neuroreport 11: 627-631.
22. Dumbrille-Ross A. and Tang SW (1981) Absence of high-ffinity [3H]imipramine binding in platelets and cerebral cortex of fawn-hooded rats. Eur J Pharmacol 72: 137-138.
23. Einat H., Belmaker RH, Zangen A, Overstreet DH, and Yadid G (2002) Chronic inositol treatment reduces depression-like immobility of Flinders Sensitive Line rats in the forced swim test. Depress Anxiety 15:148-151.
24. Elfving B., Plougmann PH, Müller HK, Mathé AA, Rosenberg R, and Wegener G (2010a) Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol 13:563-572.
25. Elfving B., Plougmann PH, and Wegener G (2010b) Differential brain, but not serum VEGF levels in a genetic rat model of depression. Neurosci Lett 474:13-16.
26. Fagergren P., Overstreet DH, Goiny M, and Hurd YL (2005) Blunted response to cocaine in the Flinders hypercholinergic animal model of depression. Neuroscience 132:1159-1171.
27. Feighner J. P, Sverdlov L, Nicolau G, Abajian HB, Hlavka J, Freed JS, and Tonelli G Jr (2003) Clinical effectiveness of nemifitide, a novel pentapeptide antidepressant, in depressed outpatients: comparison of follow-up re-treatment with initial treatment. Int J Neuropsychopharmacol 6:207-213.
28. File S. E and Seth P (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53.
29. Fischer C. W, Liebenberg N, Elfving B, Lund S, and Wegener G (2012) Isolationinduced behavioural changes in a genetic animal model of depression. Behav Brain Res 230:85-91.
30. Friedman E., Berman M, and Overstreet DH (2006) Swim test immobility in a genetic rat model of depression is modified by maternal environment: a cross-foster study. Dev Psychobiol 48:169-177.
31. Friedman A., Lax E, Abraham L, Tischler H, and Yadid G (2012) Abnormality of VTA local field potential in an animal model of depression was restored by patterned DBS treatment. Eur Neuropsychopharmacol 22:64-71.
32. Furey M. L and Drevets WC (2006) Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial. Arch Gen Psychiatry 63:1121-1129.
33. Furey M. L, Khanna A, Hoffman EM, and Drevets WC (2010) Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology 35:2479-2488.
34. Gómez-Galán M., De Bundel D, Van Eeckhaut A, Smolders I, and Lindskog M (2012) Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression. Mol Psychiatry DOI: [published ahead of print].
35. Green B. (2011) Focus on agomelatine. Curr Med Res Opin 27:745-749.
36. Green P., Anyakoha N, Yadid G, Gispan-Herman I, and Nicolaou A (2009) Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. Prostaglandins Leukot Essent Fatty Acids 80:213-220.
37. Gutman D. A, Coyer MJ, Boss-Williams KA, Owens MJ, Nemeroff CB, and Weiss JM (2008) Behavioral effects of the CRF1 receptor antagonist R121919 in rats selectively bred for high and low activity in the swim test. Psychoneuroendocrinology 33: 1093-1101.
38. Hansson A. C, Rimondini R, Heilig M, Mathé AA, and Sommer WH (2011) Dissociation of antidepressant-like activity of escitalopram and nortriptyline on behaviour and hippocampal BDNF expression in female rats. J Psychopharmacol 25: 1378-1387.
39. Hascup K. N, Hascup ER, Stephens ML, Glaser PE, Yoshitake T, Mathé AA, Gerhardt GA, and Kehr J (2011) Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression. Neuropsychopharmacology 36:1769-1777.
40. Hasegawa S., Nishi K, Watanabe A, Overstreet DH, and Diksic M (2006) Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study. Neurochem Int 48:358-366.
41. Henn F. A and Vollmayr B (2005) Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 29:799-804.
42. Heurteaux C., Lucas G, Guy N, El Yacoubi M, Thummer S, Peng XD, Noble F, Blondeau N., Widineau C, and Bossott OM, et al. (2006) Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9:1134-1141.
43. Hildreth C. M, Padley JR, Pilowsky PM, and Goodchild AK (2008) Impaired serotonergic regulation of heart rate may underlie reduced baroreflex sensitivity in an animal model of depression. Am J Physiol Heart Circ Physiol 294:H474-H480.
44. Holsboer F. (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:477-501.
45. Howland R. H (2009) The antidepressant effects of anticholinergic drugs. J Psychosoc Nurs Ment Health Serv 47:17-20.
46. Jaehne E. J, Majumder I, Salem A, and Irvine RJ (2011) Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression. Addict Biol 16:7-19.
47. Janowsky D. S, Risch C, Parker D, Huey LY, and Judd LL (1980) Increased vulnerability to cholinergic stimulation in affective-disorder patients [proceedings]. Psychopharmacol Bull 16:29-31.
48. Janowsky D. S, Overstreet DH, and Nurnberger JI Jr (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54:335-344.
49. Jiménez-Vasquez P. A, Overstreet DH, and Mathé AA (2000) Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli. J Psychiatr Res 34:405-412.
50. Kaae S. S, Chen F, Wegener G, Madsen TM, and Nyengaard JR (2012) Quantitative hippocampal structural changes following ECS treatment in a rat model of depression. Synapse 66:667-676. DOI: 10.1002/syn.21553
51. Kanemaru K. and Diksic M (2009) The Flinders Sensitive Line of rats, a rat model of depression, has elevated brain glucose utilization when compared to normal rats and the Flinders Resistant Line of rats. Neurochem Int 55:655-661.
52. Kanemaru K., Hasegawa S, Nishi K, and Diksic M (2008) Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: an autoradiographic evaluation. Brain Res Bull 77:214-220.
53. Kanemaru K., Nishi K, and Diksic M (2009) AGN-2979, an inhibitor of tryptophan hydroxylase activation, does not affect serotonin synthesis in Flinders Sensitive Line rats, a rat model of depression, but produces a significant effect in Flinders Resistant Line rats. Neurochem Int 55:529-535.
54. Keller J., Flores B, Gomez RG, Solvason HB, Kenna H, Williams GH, and Schatzberg AF (2006) Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 60:275-281.
55. Kokras N., Antoniou K, Dalla C, Bekris S, Xagoraris M, Ovestreet DH, and Papadopoulou-Daifoti Z (2009) Sex-related differential response to clomipramine treatment in a rat model of depression. J Psychopharmacol 23:945-956.
56. Kokras N., Sotiropoulos I, Pitychoutis PM, Almeida OF, and Papadopoulou-Daifoti Z (2011) Citalopram-mediated anxiolysis and differing neurobiological responses in both sexes of a genetic model of depression. Neuroscience 194:62-71.
57. Kotsovolou O., Ingelman-Sundberg M, Lang MA, Marselos M, Overstreet DH, Papadopoulou-Daifoti Z., Johanson I, Fotopoulos A, and Konstandi M (2010) Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 34:1075-1084.
58. Kovacevic T, Skelin I, and Diksic M (2010) Chronic fluoxetine treatment has a larger effect on the density of a serotonin transporter in the Flinders Sensitive Line (FSL) rat model of depression than in normal rats. Synapse 64:231-240.
59. Kovacevic T, Skelin I, Minuzzi L, Rosa-Neto P, and Diksic M (2012) Reduced metabotropic glutamate receptor 5 in the Flinders Sensitive Line of rats, an animal model of depression: an autoradiographic study. Brain Res Bull 87:406-412.
60. Lahmame A., del Arco C, Pazos A, Yritia M, and Armario A (1997) Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants? Eur J Pharmacol 337:115-123.
61. Lahmame A. and Armario A (1996) Differential responsiveness of inbred strains of rats to antidepressants in the forced swimming test: are Wistar Kyoto rats an animal model of subsensitivity to antidepressants? Psychopharmacology (Berl) 123:191-198.
62. Lavi-Avnon Y., Yadid G, Overstreet DH, and Weller A (2005) Abnormal patterns of maternal behavior in a genetic animal model of depression. Physiol Behav 84: 607-615.
63. Lazary J., Juhasz G, Anderson IM, Jacob CP, Nguyen TT, Lesch KP, Reif A, Deakin JF, and Bagdy G (2011) Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality. Eur Neuropsychopharmacol 21:63-70.
64. Liebenberg N., Harvey BH, Brand L, and Brink CB (2010) Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression. Behav Pharmacol 21:540-547.
65. Liebenberg N., Harvey BH, Brand L, Wegener G, and Brink CB (2012) Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders Sensitive Line rats. Metab Brain Dis 27: 337-340 10.1007/s11011-012-9284-z.
66. Liou Y. J, Chen TJ, Tsai SJ, Yu YW, Cheng CY, and Hong CJ (2009) Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet Genomics 19:735-741.
67. Lodge N. J and Li YW (2008) Ion channels as potential targets for the treatment of depression. Curr Opin Drug Discov Devel 11:633-641.
68. López-Rubalcava C. and Lucki I (2000) Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test. Neuropsychopharmacology 22:191-199.
69. Majumder I., White JM, and Irvine RJ (2011) Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression. Behav Pharmacol 22:758-765.
70. Malkesman O. and Weller A (2009) Two different putative genetic models of childhood depression-a review. Prog Neurobiol 88:153-169.
71. Mathé A. A, Jimenez PA, Theodorsson E, and Stenfors C (1998) Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded "depressed", Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli. Prog Neuropsychopharmacol Biol Psychiatry 22:529-546.
72. Matriciano F., Nasca C, Molinaro G, Riozzi B, Scaccianoce S, Raggi MA, Mercolini L, Bigioni F., Mathe AA, and Sanna E, et al. (2010) Enhanced expression of the neuronal K+/Cl-co-transporter KCC2, in spontaneously depressed FSL rats. Brain Res 1325:112-120.
73. Matthews K., Baldo BA, Markou A, Lown O, Overstreet DH, and Koob GF (1996) Rewarding electrical brain stimulation: similar thresholds for Flinders Sensitive Line Hypercholinergic and Flinders Resistant Line Hypocholinergic rats. Physiol Behav 59:1155-1162.
74. Melas P. A, Rogdaki M, Lennartsson A, Bjork K, Qi H, Witasp A, Werme M, Wegener G, Mathe AA, and Svenningsson P, et al. (2011) Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Internat J Neuropsychopharmacol 15:1-11.
75. Millstein R. A and Holmes A (2007) Effects of repeated maternal separation on anxiety-and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev 31:3-17.
76. Mork A., Pehrson A, Fallon SM, Sanchez C, and Overstreet DH (2011) Coadministration of a 5-HT3 receptor antagonist augments SSRI-induced antidepressant-like effect and SSRI-induced increase in serotonin levels, in Proceedings of the 10th Meeting of World Congress of Biological Psychiatry; 2011 May 30-Jun 1; Prague, Czech Republic. Abstract P-13, World Federation of Societies of Biological Psychiatry, Barsbuttel, Germany.
77. Nishi K., Kanemaru K, and Diksic M (2009a) A genetic rat model of depression, Flinders sensitive line, has a lower density of 5-HT(1A) receptors, but a higher density of 5-HT(1B) receptors, compared to control rats. Neurochem Int 54:299-307.
78. Nishi K., Kanemaru K, Hasegawa S, Watanabe A, and Diksic M (2009b) Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats. Neurochem Int 54:205-214.
79. Overstreet D. H (1986) Selective breeding for increased cholinergic function: development of a new animal model of depression. Biol Psychiatry 21:49-58.
80. Overstreet D. H (1993) The Flinders sensitive line rats: a genetic animal model of depression. Neurosci Biobehav Rev 17:51-68.
81. Overstreet D. H (2002) Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 32: 335-348.
82. Overstreet D. H (2012) Modeling depression in animal models. Methods Mol Biol 829: 125-144.
83. Overstreet D. H and Russell RW (1982) Selective breeding for sensitivity to DFP. Effects of cholinergic agonists and antagonists. Psychopharmacology (Berl) 78: 150-154.
84. Overstreet D. H and Griebel G (2004) Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression. Eur J Pharmacol 497: 49-53.
85. Overstreet D. H and Griebel G (2005) Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat. Pharmacol Biochem Behav 82:223-227.
86. Overstreet D. H, Russell RW, Helps SC, Runge P, and Prescott AM (1979a) Sex differences following pharmacological manipulation of the cholinergic system by DFP and pilocarpine. Psychopharmacology (Berl) 61:49-58.
87. Overstreet D. H, Russell RW, Helps SC, and Messenger M (1979b) Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berl) 65:15-20.
88. Overstreet D. H, Russell RW, Crocker AD, and Schiller GD (1984) Selective breeding for differences in cholinergic function: pre-and postsynaptic mechanisms involved in sensitivity to the anticholinesterase, DFP. Brain Res 294:327-332.
89. Overstreet D. H, Booth RA, Dana R, Risch SC, and Janowsky DS (1986) Enhanced elevation of corticosterone following arecoline administration to rats selectively bred for increased cholinergic function. Psychopharmacology (Berl) 88:129-130.
90. Overstreet D. H, Russell RW, Crocker AD, Gillin JC, and Janowsky DS (1988) Genetic and pharmacological models of cholinergic supersensitivity and affective disorders. Experientia 44:465-472.
91. Overstreet D. H, Rezvani AH, and Janowsky DS (1990) Increased hypothermic responses to ethanol in rats selectively bred for cholinergic supersensitivity. Alcohol Alcohol 25:59-65.
92. Overstreet D. H, Russell RW, Hay DA, and Crocker AD (1992) Selective breeding for increased cholinergic function: biometrical genetic analysis of muscarinic responses. Neuropsychopharmacology 7:197-204.
93. Overstreet D. H, Janowsky DS, Pucilowski O, and Rezvani AH (1994) Swim test immobility co-segregates with serotonergic but not cholinergic sensitivity in crossbreeds of Flinders Line rats. Psychiatr Genet 4:101-107.
94. Overstreet D. H, Pucilowski O, Rezvani AH, and Janowsky DS (1995) Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacology (Berl) 121:27-37.
95. Overstreet D. H, Miller CS, Janowsky DS, and Russell RW (1996) Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. Toxicology 111:119-134.
96. Overstreet D. H, Daws LC, Schiller GD, Orbach J, and Janowsky DS (1998a) Cholinergic/serotonergic interactions in hypothermia: implications for rat models of depression. Pharmacol Biochem Behav 59:777-785.
97. Overstreet D. H, Pucilowski O, Retton MC, Delagrange P, and Guardiola-Lemaitre B (1998b) Effects of melatonin receptor ligands on swim test immobility. Neuroreport 9:249-253.
98. Overstreet D. H, Keeney A, and Hogg S (2004a) Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression. Eur J Pharmacol 492:195-201.
99. Overstreet D. H, Hlavka J, Feighner JP, Nicolau G, and Freed JS (2004b) Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression. Psychopharmacology (Berl) 175:303-309.
100. Overstreet D. H, Friedman EF, Mathé AA, and Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739-759.
101. Overstreet D. H, Rezvani AH, Djouma E, Parsian A, and Lawrence AJ (2007) Depressive-like behavior and high alcohol drinking co-occur in the FH/WJD rat but appear to be under independent genetic control. Neurosci Biobehav Rev 31: 103-114.
102. Overstreet D. H, Stemmelin J, and Griebel G (2008) Confirmation of antidepressant potential of the selective beta3 adrenoceptor agonist amibegron in an animal model of depression. Pharmacol Biochem Behav 89:623-626.
103. Overstreet D. H, Naimoli VM, and Griebel G (2010a) Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression. Pharmacol Biochem Behav 96:206-210.
104. Overstreet D. H, Fredericks K, Knapp D, Breese G, and McMichael J (2010b) Nerve growth factor (NGF) has novel antidepressant-like properties in rats. Pharmacol Biochem Behav 94:553-560.
105. Owens W. A, Aguilar D, Overstreet DH, and Daws LC (2011) SERT-ainly slower: Reduced SERT expression and function in the Flinders Sensitive Line (FSL) rat model of depression. Presented at meeting of Society for Neuroscience, DC November, Washington.
106. Padley J. R, Overstreet DH, Pilowsky PM, and Goodchild AK (2005) Impaired cardiac and sympathetic autonomic control in rats differing in acetylcholine receptor sensitivity. Am J Physiol Heart Circ Physiol 289:H1985-H1992.
107. Paré W. P (1989) Stress ulcer susceptibility and depression in Wistar Kyoto (WKY) rats. Physiol Behav 46:993-998.
108. Paré W. P (1992) The performance of WKY rats on three tests of emotional behavior. Physiol Behav 51:1051-1056.
109. Paré W. P and Redei E (1993) Depressive behavior and stress ulcer in Wistar Kyoto rats. J Physiol Paris 87:229-238.
110. Pepe S., Overstreet DH, and Crocker AD (1988) Enhanced benzodiazepine responsiveness in rats with increased cholinergic function. Pharmacol Biochem Behav 31:15-19.
111. Petersén A., Wörtwein G, Gruber SH, El-Khoury A, and Mathé AA (2009) Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 451:148-151.
112. Pettinati H. M (2004) Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 56:785-792.
113. Piubelli C., Carboni L, Becchi S, Mathé AA, and Domenici E (2011a) Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis. Neuroscience 176:349-380.
114. Piubelli C., Gruber S, El Khoury A, Mathé AA, Domenici E, and Carboni L (2011b) Nortriptyline influences protein pathways involved in carbohydrate metabolism and actin-related processes in a rat gene-environment model of depression. Eur Neuropsychopharmacol 21:545-562.
115. Piubelli C., Vighini M, Mathé AA, Domenici E, and Carboni L (2011c) Escitalopram modulates neuron-remodelling proteins in a rat gene-environment interaction model of depression as revealed by proteomics. Part I: genetic background. Int J Neuropsychopharmacol 14:796-833.
116. Piubelli C., Vighini M, Mathé AA, Domenici E, and Carboni L (2011d) Escitalopram affects cytoskeleton and synaptic plasticity pathways in a rat gene-environment interaction model of depression as revealed by proteomics. Part II: environmental challenge. Int J Neuropsychopharmacol 14:834-855.
117. Pryce C. R, Azzinnari D, Spinelli S, Seifritz E, Tegethoff M, and Meinlschmidt G (2011) Helplessness: a systematic translational review of theory and evidence for its relevance to understanding and treating depression. Pharmacol Ther 132: 242-267.
118. Pucilowski O. and Overstreet DH (1993) Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res Bull 32: 471-475.
119. Pucilowski O., Overstreet DH, Rezvani AH, and Janowsky DS (1991) Effects of calcium channel inhibitors on the hypothermic response to oxotremorine in normo and hypercholinergic rats. J Pharm Pharmacol 43:436-439.
120. Pucilowski O., Overstreet DH, Rezvani AH, and Janowsky DS (1993) Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 54:1215-1220.
121. Rezvani A. H, Overstreet DH, Cleves A, and Parsian A (2007) Further genetic characterization of the fawn-Hooded (FH/Wjd) rat, an animal model of comorbid depression and alcoholism. Psychiatr Genet 17:72-83.
122. Risch S. C, Kalin NH, and Janowsky DS (1981) Cholinergic challenge in affective illness: behavioral and neuroendocrine correlates. J Clin Psychopharmacol 1: 186-192.
123. Russell R. W and Overstreet DH (1987) Mechanisms underlying sensitivity to organophosphorus anticholinesterase compounds. Prog Neurobiol 28:97-129.
124. Russell R. W, Overstreet DH, Messenger M, and Helps SC (1982) Selective breeding for sensitivity to DFP: generalization of effects beyond criterion variables. Pharmacol Biochem Behav 17:885-891.
125. Russell R. W, Overstreet DH, and Netherton RA (1983) Sex-linked and other genetic factors in the development of tolerance to the anticholinesterase, DFP. Neuropharmacology 22:75-81.
126. Sansone R. A and Sansone LA (2011) Agomelatine: a novel treatment. Innov Clin Neurosci 8:10-14.
127. Sato H., Skelin I, and Diksic M. (2011) Acute desipramine treatment reduces regional serotonin synthesis rates, while chronic treatment elevates rates, in a rat model of depression. An autoradiographic study. Neurochem Int 58:759-766.
128. Schiller G. D, Daws LC, Overstreet DH, and Orbach J (1991) Lack of anxiety in an animal model of depression with cholinergic supersensitivity. Brain Res Bull 26: 433-435.
129. Schiller G. D and Overstreet DH (1993) Selective breeding for increased cholinergic function: Preliminary study of nicotinic mechanisms. Med Chem Res 2: 578-583.
130. Schiller G. D, Pucilowski O, Wienicke C, and Overstreet DH (1992) Immobilityreducing effects of antidepressants in a genetic animal model of depression. Brain Res Bull 28:821-823.
131. Shiromani P. J, Overstreet DH, Levy D, Goodrich CA, Campbell SS, and Gillin JC (1988) Increased REM sleep in rats selectively bred for cholinergic hyperactivity. Neuropsychopharmacology 1:127-133.
132. Sihotang K. and Overstreet DH. (1983) Studies of a possible relationship of brain proteins to behavioral sensitivity to DFP. Life Sci. 32:4l3-420.
133. Solskov L., Løfgren B, Pold R, Kristiansen SB, Nielsen TT, Overstreet DH, Schmitz O, Bøtker H. E, Lund S, and Wegener G (2010) Evaluation of the relationship between hyperinsulinaemia and myocardial ischaemia/reperfusion injury in a rat model of depression. Clin Sci (Lond) 118:259-267.
134. Tabb K., Boss-Williams KA, Weiss JM, and Weinshenker D (2007) Rats bred for susceptibility to depression-like phenotypes have higher kainic acid-induced seizure mortality than their depression-resistant counterparts. Epilepsy Res 74: 140-146.
135. Tfilin M., Sudai E, Merenlender A, Gispan I, Yadid G, and Turgeman G (2010) Mesenchymal stem cells increase hippocampal neurogenesis and counteract depressive-like behavior. Mol Psychiatry 15:1164-1175.
136. Tizabi Y., Overstreet DH, Rezvani AH, Louis VA, Clark E Jr, Janowsky DS, and Kling MA (1999) Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology (Berl) 142:193-199.
137. Touma C., Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstatter M, Zeh R, Zimbelmann M, and Holsboer F, et al. (2008) Mice selected for high versus low stress reactivity: a new animal model for affective disorders. Psychoneuroendocrinology 33:839-862.
138. Tsai S. J (2008) Sipatigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two pore domain K+ channel TREK-1. Med Hypotheses 40:548-550.
139. Vollmayr B., Faust H, Lewicka S, and Henn FA (2001) Brain-derived-neurotrophicfactor (BDNF) stress response in rats bred for learned helplessness. Mol Psychiatry 6:471-474, 358.
140. Vollmayr B. and Henn FA (2001) Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 8:1-7.
141. Walker M. W, Wolinsky TD, Jubian V, Chandrasena G, Zhong H, Huang X, Miller S, Hegde L. C, Marstekker DA, and Marzabadi MR, et al. (2009) The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 exerts anxiolytic-like and antidepressant-like effects in rat models of stress sensitivity. J Pharmacol Exp Ther 328:900-911.
142. Wallis E., Overstreet DH, and Crocker AD (1988) Selective breeding for increased cholinergic function: increased serotonergic sensitivity. Pharmacol Biochem Behav 31:345-350.
143. Wegener G., Harvey BH, Bonefeld B, Müller HK, Volke V, Overstreet DH, and Elfving B (2010) Increased stress-evoked nitric oxide signalling in the Flinders sensitive line (FSL) rat: a genetic animal model of depression. Int J Neuropsychopharmacol 13:461-473.
144. Wegener G., Finger BC, Elfving B, Keller K, Liebenberg N, Fischer CW, Singewald N, Slattery D. A, Neumann ID, and Mathé AA (2011) Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression. Int J Neuropsychopharmacol 9:1-13.
145. Wegener G., Mathe AA, and Neumann ID (2012) Selectively bred rodents as models of depression and anxiety. Curr Top Behav Neurosci 12:139-187.
146. Wegener G. and Mathé AA. (2011) Nitric Oxide Signaling in Depression and Antidepressant Action, in Neurobiology of Depression, pp 341-370, CRC Press, Boca Raton, FL.
147. Weiss J. M, Cierpial MA, and West CH (1998) Selective breeding of rats for high and low motor activity in a swim test: toward a new animal model of depression. Pharmacol Biochem Behav 61:49-66.
148. West C. H, Bonsall RW, Emery MS, and Weiss JM (1999a) Rats selectively bred for high and low swim-test activity show differential responses to dopaminergic drugs. Psychopharmacology (Berl) 146:241-251 Berl.
149. West C. H, Boss-Williams KA, and Weiss JM (1999b) Motor activation by amphetamine infusion into nucleus accumbens core and shell subregions of rats differentially sensitive to dopaminergic drugs. Behav Brain Res 98:155-165.
150. West C. H and Weiss JM (1998) Effects of antidepressant drugs on rats bred for low activity in the swim test. Pharmacol Biochem Behav 61:67-79.
151. Will C. C, Aird F, and Redei EE (2003) Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants. Mol Psychiatry 8:925-932.
152. Willner P. (2005) Chronic mild stress (CMS) revisited: consistency and behaviouralneurobiological concordance in the effects of CMS. Neuropsychobiology 52:90-110.
153. Wu G., Feder A, Wegener G, Bailey C, Saxena S, Charney D, and Mathé AA (2011) Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets 15:1317-1331.
154. Zangen A., Overstreet DH, and Yadid G (1997) High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 69:2477-2483.
155. Zangen A., Nakash R, Overstreet DH, and Yadid G (2001) Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology (Berl) 155:434-439.